Dr. Vander Heide completed his residency in Anatomic Pathology at Duke University from 1989-1993. His first position was at Wayne State University Medical School in Detroit, Michigan where he was the Residency Program Director for 5 years and was named as Best Pathology instructor by the sophomore medical student class 3 times. He was Chief of Pathology at the John D. Dingell VA Medical Center from 2000-2009. His primary research interest is myocardial cell injury and adaptation; specifically in response to ischemia/reperfusion injury.

Clinical Interests

Cardiovascular pathology, autopsy pathology, COVID-19

Research Interests

Ischemia/Reperfusion Injury,
Novel Drug Delivery for Ischemic Injury
Cell Signaling

Teaching Activities

Medical school education and teaching

Selected Publications

Perricone AJ, Vander Heide RS: Novel Therapeutic Strategies for Ischemic Heart Disease. Pharmacol Res 2014 Nov; 89:36-45. Doi: 10.1016/j.phrs.2014.08.004.

Buja LM, Vander Heide RS: Pathobiology of Ischemic Heart Disease: Past, Present and Future. Cardiovasc Path 2016 Feb 2;25(3):214-220. doi: 10.1016/j.carpath.2016.01.007.

Fox Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. The Lancet Respiratory Medicine, 8(7): 681-686. (2020). https://doi.org/10.1016/S2213-2600(20)30243-5

Fox SE, Li G, Akmatbekov A, Harbert JL, Lameira FS, Brown JQ, Vander Heide RS. Unexpected Features of Cardiac Pathology in Covid-19 Infection. Circulation, ePub ahead of print, July 21, 2020. https://doi.org/10.1161/CIRCULATIONAHA.120.049465

Additional Info

Diplomate, American Board of Pathology, 1993 Fellow, College of American Pathologists, FAHA, Ameican Heart Association

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .